Dealmaking Quarterly Statistics, Q1 2021: Boston Scientific, Roche Start The Year With Billion-Dollar-Plus Acquisitions
A Look At M&A And Alliance Activity Across Medical Device And In Vitro Diagnostics Industries, January-March 2021
During the first quarter, medical device company mergers and acquisition totalled $10.2bn, while in vitro diagnostic firms and research tools players completed M&A activity that totaled $5bn.
You may also be interested in...
In its first quarter 2021 sales earnings report, Roche highlighted the strength of its diagnostics business as biosimilars cannibalize its pharmaceutical revenues.
With the addition of Decipher, Veracyte now offers tests for seven of the 10 most common types of cancer in the US.
Cardinal said it remains “committed to its medical distribution and global medical products businesses” despite the divesture of Cordis.